The therapeutic proteins market report from The Business Research Company covers growth-driving insights such as therapeutic proteins market size, therapeutic proteins market trends and drivers, therapeutic proteins market segmentation, therapeutic proteins market competitive landscape and more

The therapeutic proteins market is forecasted to achieve notable growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 12%, as per The Business Research Company’s market report!

Read More On The Therapeutic Proteins Market Report 2022 – https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

The Therapeutic Proteins Market Size In 2022 And Forecast

The global therapeutic proteins market is expected to grow from $100.06 billion in 2021 to $112.17 billion in 2022 at a compound annual growth rate (CAGR) of 12.1%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The therapeutic protein market is expected to reach $177.30 billion in 2026 at a CAGR of 12.1%.

The therapeutic proteins market consists of sales of therapeutic proteins. Therapeutic proteins provide important therapies for diseases such as diabetes, cancer, infectious diseases, hemophilia, and anemia.

Request for A Sample Of The Global Therapeutic Proteins Market Report:

 https://www.thebusinessresearchcompany.com/sample.aspx?id=2555&type=smp

Advance Technologies For Protein-Based Drug Development Is Driving The Growth Of The Therapeutic Proteins Market

Therapeutic proteins cannot be synthesized chemically, they need to be produced by genetic engineering and recombinant DNA technology in living cells or organisms. Protein-engineering platform technologies such as glycoengineering, pegylation, Fc-fusion, albumin fusion, albumin drug conjugation help to increase the production yield, product purity, circulating half-life, targeting, and functionality of therapeutic protein drugs. Belimumab, ipilimumab, taliglucerase alfa, albiglutide, coagulation factor IX recombinant human are some therapeutic protein drugs developed using protein engineering technologies approved by FDA in the past five years.

Competitive Landscape And The Regional Analysis Of The Therapeutic Proteins Market

Major players in the therapeutic proteins market are Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Pfizer Inc, Johnson & Johnson, Merck & Co. Inc, Novo Nordisk A/S and Sanofi.

The Therapeutic Proteins Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the therapeutic proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the therapeutic proteins market.

Increasing Monoclonal Antibody Drug Approvals – A Key Trend In The Therapeutic Proteins Market

Chronic diseases such as cancer, immunological disorders are well treated with monoclonal antibodies. Monoclonal antibodies are dominant and well-established product class in the protein therapeutic segment with more safety and immunogenicity than antibodies. Cell-based expression systems such as Chinese hamster ovary (CHO) mammalian cell expression system with latest technologies increased the productivity of monoclonal antibodies by overcoming the problems associated with earlier antibody drugs. In last five years, FDA approved 213 drugs, among them 44 are monoclonal antibodies.

Therapeutic Proteins Market Segmentation By The Business Research Company

1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone

2) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others

3) By Function: Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics

Here Are Some Reports Related To The Therapeutic Proteins Market –

Protein Expression Global Market Report 2022

Protein Labeling Global Market Report 2022

Protein Inhibitors Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: